Latest News
Shanghai Electric odnotowuje wzrost przychodów o 16,6% w I półroczu 2026 r., a wartość nowych zamówień sięga 100,39 mld CNY
/PRNewswire/ -- Spółka Shanghai Electric (SEHK: 02727, SSE: 601727) opublikowała wyniki okresowe za pierwsze półrocze 2026 r. W okresie sprawozdawczym firma
Shanghai Electric verzeichnet im ersten Halbjahr 2026 ein Umsatzwachstum von 16,6 %; Auftragseingang erreicht 100,39 Milliarden CNY
/PRNewswire/ -- Shanghai Electric (SEHK: 02727, SSE: 601727) hat seine Halbjahresergebnisse für das erste Halbjahr 2026 veröffentlicht. Im Berichtszeitraum
Shanghai Electric oznámila za první pololetí roku 2026 nárůst tržeb o 16,6% a objem nových zakázek dosáhl 100,39 miliardy jüanů
/PRNewswire/ -- Společnost Shanghai Electric (SEHK: 02727, SSE: 601727) zveřejnila své předběžné výsledky za první pololetí roku 2026. Během sledovaného období
Teva Says Pivot to Growth Gains Steam as Branded Drugs, Biosimilars Outperform
Teva Pharmaceutical Industries NYSE: TEVA CEO Richard Francis said the company has progressed from the initial phase of its “Pivot to Growth” plan into its next stage, citing momentum in branded medic
Fractyl Health, Inc. (GUTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Fractyl Health, Inc. (GUTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
CG Oncology, Inc. (CGON) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
CG Oncology, Inc. (CGON) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Microsoft CEO Satya Nadella posts an internal warning to employees about AI safety
Satya Nadella urged the AI industry to prioritize safety and maintain human control over technology. The Microsoft CEO supports third-party AI testing amid industry debate over development pace.
Mastercard CFO Outlines Growth Strategy Driven by Stablecoins and Value-Added Services
Incoming Mastercard Chief Financial Officer Ling Hai, who assumed that role Aug. 3, outlined a growth-focused capital allocation strategy that includes frontline sales, targeted acquisition and infras
Corteva Categorically Rejects Unfounded, Unprecedented Allegations by State Attorneys General
Future crop protection company will be a strongly capitalized market leader with compelling value proposition for farmers, shareholders INDIANAPOLIS, Sept. 14, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE
United Therapeutics Corporation (UTHR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
United Therapeutics Corporation (UTHR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
MindWalk Holdings Corp. (HYFT) Q1 2027 Earnings Call Transcript
MindWalk Holdings Corp. (HYFT) Q1 2027 Earnings Call Transcript
Denali Therapeutics Inc. (DNLI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Denali Therapeutics Inc. (DNLI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Cellebrite DI Ltd. (CLBT) Discusses Leadership Transition and Strategic Focus on Growth and Execution Transcript
Cellebrite DI Ltd. (CLBT) Discusses Leadership Transition and Strategic Focus on Growth and Execution Transcript
Zymeworks Inc. (ZYME) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Zymeworks Inc. (ZYME) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Radiant Logistics, Inc. (RLGT) Q4 2026 Earnings Call Transcript
Radiant Logistics, Inc. (RLGT) Q4 2026 Earnings Call Transcript
East West Bancorp, Inc. (EWBC) Presents at Barclays 24th Annual Global Financial Services Conference Transcript
East West Bancorp, Inc. (EWBC) Presents at Barclays 24th Annual Global Financial Services Conference Transcript
Samsung backs Nvidia AI chip rival in $230 million funding round as GPU alternatives boom
Dutch startup Euclyd, which is a building a chip for AI inference that seeks to rival Nvidia, has raised $230 million funding round. The round was co-led by Samsung, Somerset Capital Partners, the Sca
Dave & Buster's Entertainment Q2 Earnings Call Highlights
Dave & Buster's Entertainment NASDAQ: PLAY reported lower second-quarter revenue and earnings but said same-store sales trends improved during July and the early weeks of its third quarter as the comp
CRISPR Therapeutics Eyes CASGEVY Growth, Year-End Pipeline Catalysts
CRISPR Therapeutics NASDAQ: CRSP CEO Sam Kulkarni outlined the company's commercial and clinical priorities during a Morgan Stanley discussion, highlighting continued adoption of CASGEVY and expected
Tech CEO warns centralized AI power could lead to 'counterfeit' humans, technocrats seeking control
Patmos CEO John Johnson argues the U.S. must decentralize AI infrastructure beyond Silicon Valley to compete with China and prevent a dangerous concentration of power.